Recent press releases
19. May 2015
Carsten Brockmeyer belongs to the top 20 most influential people in the Global ‘Medicine Maker Power List’ 2015
Munich – Carsten Brockmeyer, CEO of Formycon AG, has been ranked No. 12 on “The Medicine Maker Power List” 2015, an index of the 100 most influential people across the globe in the field of medicine. He appears on the list alongside global leaders from the industry, including CEOs, Nobel Prize winners, and many other celebrated scientists from the pharmaceutical world.
The list also includes names like Prof. David Baltimore, Nobel Prize winner in Physiology; Robert A. Bradway, Chairman & CEO, Amgen; Joseph Jimenez, CEO Novartis; Ian C. Read, Chairman, Pfizer; Kiran Mazumdar-Shaw, Chairperson and Managing Director of Biocon; Pascal Soriot, CEO, AstraZeneca; and many more. Carsten Brockmeyer is the only Germany based business leader on the list.
“I am very glad to be part of this prestigious list of medicine makers, it is also a great recognition for the important role biosimilars have in the global access to medicine. I also like to thank the Formycon team for their commitment to develop global quality biosimilars”, says Carsten Brockmeyer.
The Medicine Maker is a UK based publication that is distributed worldwide to industry professionals. The power list has been compiled from reader nominations with the help of expert judges and is based entirely on merit. It was developed in three stages. In stage one, The Medicine Maker invited readers to nominate those who they thought deserved recognition. In stage two, a jury of four noted medicine makers selected their top 100 from the slate of nominees: the results were consolidated into a list of 100 names. In the final stage, the jury ranked the list, and the average rankings were combined to provide the final Power List. The list can be accessed here.